Arterialization of a vein graft promotes cell cycle progression through Akt and p38 mitogen-activated protein kinase pathways: Impact of the preparation procedure

Canadian Journal of Cardiology

Volumn 23, Issue 14, 2007, Pages 1147-1154

  Chung, Ada W Y ^a,b   Wong, Jerry ^a   Luo, Honglin ^a   Hsiang, York N ^a   van Breemen, Cornelis ^a   Okon, Elena B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Department of Cardiovascular Science ^*  (Canada)

Author keywords

Bypass; Grafting; Signal transduction; Smooth muscle; Veins

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; VASODILATOR AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTERY GRAFT; ARTICLE; BLOOD VESSEL TONE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CORONARY ARTERY BYPASS SURGERY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GRAFT PATENCY; JUGULAR VEIN; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SWINE; TISSUE DIFFERENTIATION; VEIN GRAFT; ANIMAL; CELL CYCLE; CORONARY ARTERY DISEASE; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPLANTATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CORONARY DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; JUGULAR VEINS; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SWINE; TISSUE AND ORGAN PROCUREMENT;

EID: 38549140158     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70886-3     Document Type: Article

References (38)

1. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 1998;97:916-31.
2. Saunders PC, Pintucci G, Bizekis CS, et al. Vein graft arterialization causes differential activation of mitogen-activated protein kinases. J Thorac Cardiovasc Surg 2004;127:1276-84.
3. Pintucci G, Saunders PC, Gulkarov I, et al. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts. FASEB J 2006;20:398-400.
4. Miyake T, Aoki M, Shiraya S, et al. Inhibitory effects of NFκB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol 2006;41:431-40.
5. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol 2000;190:300-9.
6. Boehm M, Nabel EG. The cell cycle and cardiovascular diseases. Prog Cell Cycle Res 2003;5:19-30.
7. Stabile E, Zhou YF, Saji M, et al. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 2003;93:1059-65.
8. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004;37:449-71.
9. Zhou RH, Lee TS, Tsou TC, et al. Stent implantation activates Akt in the vessel wall: Role of mechanical stretch in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:2015-20.
10. Izumi Y, Kim S, Namba M, et al. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res 2001;88:1120-6.
11. Nath N, Wang S, Betts V, Knudsen E, Chellappan S. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases. Oncogene 2003;22:5986-94.
12. Slater SC, Koutsouki E, Jackson CL, et al. R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 2004;24:1204-10.
13. Angelini GD, Bryan AJ, Williams HM, Morgan R, Newby AC. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 1990;99:433-9.
14. Chung AW, Rauniyar P, Luo H, Hsiang YN, van Breemen C, Okon EB. Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production. J Thorac Cardiovasc Surg 2006;132:925-32.
15. Chung AW, Rauniyar P, Luo H, Hsiang YN, van Breemen C, Okon EB. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9. J Vasc Surg 2005;42:747-56.
16. Li C, Hu Y, Mayr M, Xu Q. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J Biol Chem 1999;274:25273-80.
17. Uglow EB, Slater S, Sala-Newby GB, et al. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 2003;92:1314-21.
18. Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation 2003;108:616-22.
19. Rössig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem 2002;227:9684-9.
20. Mourani PM, Garl PJ, Wenzlau JM, Carpenter TC, Stenmark KR, Weiser-Evans MC. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Circulation 2004;109:1299-306.
21. Angelini GD, Breckenridge IM, Psaila JV, Williams HM, Henderson AH, Newby AC. Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin. Cardiovasc Res 1987;21:28-33.
22. Liu ZG, Liu XC, Yim AP, He GW. Direct measurement of nitric oxide release from saphenous vein: Abolishment by surgical preparation. Ann Thorac Surg 2001;71:133-7.
23. Crowley CM, Lee CH, Gin SA, Keep AM, Cook RC, van Breemen C. The mechanism of excitation-contraction coupling in phenylephrine-stimulated human saphenous vein. Am J Physiol Heart Circ Physiol 2002;283:H1271-81.
24. Okon EB, Millar MJ, Crowley CM, et al. Effect of moderate pressure distention on the human saphenous vein vasomotor function. Ann Thotac Surg 2004;77:108-14.
25. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arteriosclet Thromb Vasc Biol 2003;23:1510-20.
26. Zhan Y, Kim S, Izumi Y, et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 2003;23:795-801.
27. Pyles JM, March KL, Franklin M, Mehdi K, Wilensky RL, Adam LP. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res 1997;81:904-10.
28. Nofer JR, Junker R, Pulawski E, et al. High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost 2001;85:730-5.
29. Huang J, Niu XL, Pippen AM, Annex BH, Kontos CD. Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia. Arterioscler Thromb Vasc Biol 2005;25:354-8.
30. Moon SK, Kim HM, Kim CH. PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys 2004;421:267-76.
31. Birukov KG, Lehoux S, Birukova AA, Merval R, Tkachuk VA, Tedgui A. Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture. Circ Res 1997;81:895-903.
32. Aikawa R, Nagai T, Kudoh S, et al. Integrins play a critical role in mechanical stress-induced p38 MAPK activation. Hypertension 2002;39:233-8.
33. Kawabe J, Okumura S, Lee MC, Sadoshima J, Ishikawa Y. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Cite Physiol 2004;286:H1845-52.
34. Zampetaki A, Zhang Z, Hu Y, Xu Q. Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NFκB signaling pathways. Am J Physiol Heart Circ Physiol 2005;288:H2946-54.
35. Schachner T. Pharmacologic inhibition of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg 2006;131:1065-72.
36. Shibata R, Kai H, Seki Y, et al. Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 2001;103:284-9.
37. Nakaki T, Nakayama M, Yamamoto S, Kato R. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 1990;37:30-6.
38. Gökçe O, Gökçe C, Günel S, et al. Preventive effect of nicardipine on hyperplastic changes in venous bypass grafts. World J Surg 1993;17:94-9.